AirStrip Secures $50 Million Growth Credit Commitment and Additional Equity Investment from OrbiMed to Accelerate Innovation and Expansion

SAN ANTONIO, TX – October 9, 2025— AirStrip Technologies, Inc., an enterprise AI healthcare technology company pioneering next-generation remote patient monitoring and clinical intelligence solutions, today announced it has entered into a committed $50 million credit facility with OrbiMed, a leading global healthcare investment firm. OrbiMed also made a preferred stock investment in AirStrip. BTIG, LLC acted as exclusive placement agent and strategic advisor for the transaction.

The funding will accelerate AirStrip’s growth strategy as demand increases for its solutions in patient monitoring, clinical surveillance, decision support, and alarm management. Proceeds will be used to expand product innovation, scale go-to-market initiatives and drive rapid deployment across health systems and hospitals nationwide.

Scaling to Meet Healthcare’s Rising Demands

AirStrip currently serves more than 675 hospitals across the United States, enabling clinicians to securely access near real-time clinical data from mobile devices and the web. This new financing will support AirStrip’s continued expansion into the broader U.S. hospital market of more than 6,000 facilities, fueling investments in product development, customer implementations, and workforce growth.

AirStrip’s portfolio includes

• Clinical Surveillance & Monitoring: Continuous, mobile-enabled monitoring across care settings including obstetrics, cardiology, patient monitoring, and alarm management to improve situational awareness and accelerate decisions.
• Clinical Decision Support: Integrated, digital protocol management that turns fragmented data into actionable insights for timely clinical action.
• Predictive Analytics: Intelligent tools, such as alarm and insight analytics, AHI predictive indicators, and telemetry optimization, which transform data into foresight for safer, more informed care.

“This funding will accelerate our transformation of how clinicians access and act on critical clinical information,” said Haris Naseem, MD, CEO of AirStrip. “We’re unifying fragmented data and delivering timely, actionable insights to facilitate improved decision-making and enhanced patient safety at every stage of care.”

“OrbiMed seeks to partner with companies that deliver meaningful, sustainable impacts in healthcare,” said Matthew Rizzo, General Partner, OrbiMed. “AirStrip is a proven leader with tremendous potential, and we’re excited to participate in their next phase of growth and innovation.”

About AirStrip®

AirStrip is a leader in clinical surveillance, decision support, and alarm management solutions. Trusted by more than 675 hospitals and health systems across the U.S., AirStrip delivers actionable, data-driven insights that help clinicians improve patient outcomes and operational efficiency. Learn more at www.airstrip.com.

About OrbiMed

OrbiMed is a leading healthcare investment firm, with over $17 billion in assets under management. OrbiMed invests globally across the healthcare industry, from start-ups to large multinational corporations, through private equity funds, public equity funds, and royalty/credit funds. OrbiMed seeks to be a capital provider of choice, providing tailored financing solutions and extensive global team resources to help build world-class healthcare companies. OrbiMed's team of over 130 professionals is based in New York City, London, San Francisco, Shanghai, Hong Kong, Mumbai, Herzliya, and other key global markets.

Media Contact:

‍Jen Hodson
Public Relations
jen@nant.com

‍